Zejula (niraparib)

pCPA File Number: 21304
Negotiation Status:
Concluded with an LOI
Indication(s):
Ovarian Cancer, monotherapy for the maintenance treatment of female adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CDA-AMC Project Number:
PC0203-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: